Cargando…
Sulfotyrosine Recognition as Marker for Druggable Sites in the Extracellular Space
Chemokine signaling is a well-known agent of autoimmune disease, HIV infection, and cancer. Drug discovery efforts for these signaling molecules have focused on developing inhibitors targeting their associated G protein-coupled receptors. Recently, we used a structure-based approach directed at the...
Autores principales: | Ziarek, Joshua J., Heroux, Maxime S., Veldkamp, Christopher T., Peterson, Francis C., Volkman, Brian F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3131587/ https://www.ncbi.nlm.nih.gov/pubmed/21747703 http://dx.doi.org/10.3390/ijms12063740 |
Ejemplares similares
-
CCR7 Sulfotyrosine Enhances CCL21 Binding
por: Phillips, Andrew J., et al.
Publicado: (2017) -
Differences in Sulfotyrosine Binding amongst CXCR1 and CXCR2 Chemokine Ligands
por: Moussouras, Natasha A., et al.
Publicado: (2017) -
Sulfotyrosine residues: Interaction specificity determinants for extracellular protein–protein interactions
por: Stewart, Valley, et al.
Publicado: (2022) -
Functional genetic encoding of sulfotyrosine in mammalian cells
por: He, Xinyuan, et al.
Publicado: (2020) -
Predicting sulfotyrosine sites using the random forest algorithm with significantly improved prediction accuracy
por: Yang, Zheng Rong
Publicado: (2009)